Shaping Up Zn Doped Magnetite Nanoparticles from Mono and Bimetallic Oleates The Impact of Zn Content, Fe Vacancies, and Morphology on Magnetic Hyperthermia Performance

The currently existing magnetic hyperthermia treatments usually need to employ very large doses of magnetic nanoparticles MNPs and or excessively high excitation conditions H f gt; 1010 A m s to reach the therapeutic temperature range that triggers cancer cell death. To make this anticancer therapy truly minimally invasive, it is crucial the development of improved chemical routes that give rise to monodisperse MNPs with high saturation magnetization and negligible dipolar interactions. Herein, we present an innovative chemical route to synthesize Zn doped magnetite NPs based on the thermolysis of two kinds of organometallic precursors i a mixture of two monometallic oleates FeOl ZnOl , and ii a bimetallic ironzinc oleate Fe3 amp; 8722;yZnyOl . These approaches have allowed tailoring the size 10 amp; 8722;50 nm , morphology spherical, cubic, and cuboctahedral , and zinc content ZnxFe3 amp; 8722;xO4, 0.05 lt; x lt; 0.25 of MNPs with high saturation magnetization amp; 8805;90 Am2 kg at RT . The oxidation state and the local symmetry of Zn2 and Fe2 3 cations have been investigated by means of X ray absorption near edge structure XANES spectroscopy, while the Fe center distribution and vacancies within the ferrite lattice have been examined in detail through Mo amp; 776;ssbauer spectroscopy, which has led to an accurate determination of the stoichiometry in each sample. To achieve good biocompatibility and colloidal stability in physiological conditions, the ZnxFe3 amp; 8722;xO4 NPs have been coated with high molecular weight poly ethylene glycol PEG . The magnetothermal efficiency of ZnxFe3 amp; 8722;xO4 PEG samples has been systematically analyzed in terms of composition, size, and morphology, making use of the latest generation AC magnetometer that is able to reach 90 mT. The heating capacity of Zn0.06Fe2.94O4 cuboctahedrons of 25 nm reaches a maximum value of 3652 W g at 40 kA m and 605 kHz , but most importantly, they reach a highly satisfactory value 600 W g under strict safety excitation conditions at 36 kA m and 125 kHz . Additionally, the excellent heating power of the system is kept identical both immobilized in agar and in the cellular environment, proving the great potential and reliability of this platform for magnetic hyperthermia therapie

A Novel Noninvasive Method Based on Salivary Inflammatory Biomarkers for the Screening of Celiac Disease

This study was supported by a grant from theSpanish Ministry of Science, Universities andInnovation (SAF2017-91873-EXP), a grant fromthe Department of Health from the BasqueGovernment (EJ-2017111082), and a researchfellowship from the Asociación de Celiacos ySensibles al Gluten de Madrid (A.C.R.). Alsosupported by a predoctoral fellowship from theUniversity of the Basque Country (M.S.dlC.) andthe Basque Government (A.O.G.)

The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA

The vast majority of type 1 diabetes (T1D) genetic association signals lie in noncoding regions of the human genome. Many have been predicted to affect the expression and secondary structure of long noncoding RNAs (lncRNAs), but the contribution of these lncRNAs to the pathogenesis of T1D remains to be clarified. Here, we performed a complete functional characterization of a lncRNA that harbors a single nucleotide polymorphism (SNP) associated with T1D, namely, Lnc13. Human pancreatic islets harboring the T1D-associated SNP risk genotype in Lnc13 (rs917997*CC) showed higher STAT1 expression than islets harboring the heterozygous genotype (rs917997*CT). Up-regulation of Lnc13 in pancreatic β-cells increased activation of the proinflammatory STAT1 pathway, which correlated with increased production of chemokines in an allele-specific manner. In a mirror image, Lnc13 gene disruption in β-cells partially counteracts polyinosinic-polycytidylic acid (PIC)-induced STAT1 and proinflammatory chemokine expression. Furthermore, we observed that PIC, a viral mimetic, induces Lnc13 translocation from the nucleus to the cytoplasm promoting the interaction of STAT1 mRNA with (poly[rC] binding protein 2) (PCBP2). Interestingly, Lnc13-PCBP2 interaction regulates the stability of the STAT1 mRNA, sustaining inflammation in β-cells in an allele-specific manner. Our results show that the T1D-associated Lnc13 may contribute to the pathogenesis of T1D by increasing pancreatic β-cell inflammation. These findings provide information on the molecular mechanisms by which disease-associated SNPs in lncRNAs influence disease pathogenesis and open the door to the development of diagnostic and therapeutic approaches based on lncRNA targeting